$ANNX Cashflow Statement | Understand Stock

$ANNX

$3.76 +$0.06 (1.62%) Close

$ANNX Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Operating activities:
Net loss
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization
Accretion of discount on available-for-sale securities
Stock-based compensation
Reduction in the carrying amount of right-of-use assets
Changes in operating assets and liabilities:
Prepaid expenses and other current assets
Other non-current assets
Accounts payable
Accrued and other current liabilities
Operating lease liabilities
Other current liabilities
Net cash used in operating activities
Investing activities:
Purchases of property and equipment
Purchases of available-for-sale securities
Proceeds from sale of available-for-sale securities
Proceeds from maturities of available-for-sale securities
Net cash provided by (used in) investing activities

Financing activities:
Proceeds from the exercise of common stock options
Proceeds from employee stock purchase plan purchases
Proceeds from the issuance of common stock, pre-funded warrants and common warrants
Proceeds from the issuance of common stock, pre-funded warrants and common warrants - related party
Payment of issuance costs related to the issuance of common stock, pre-funded warrants and common warrants
Proceeds from the issuance of common stock, pre-funded warrants and common warrants, including related party of $17,995 and $9,500 for the years ended December 31, 2023 and 2022, respectively
Proceeds from the issuance of common stock, pre-funded warrants and common warrants, including related party of $948, net of commissions
Proceeds from the issuance of common stock
Proceeds from the issuance of common stock and pre-funded warrants, net of commissions
Payment of financing costs
Net cash provided by financing activities

Increase (decrease) in cash, cash equivalents and restricted cash
Effect of exchange rate changes on cash, cash equivalents and restricted cash
Cash, cash equivalents and restricted cash
Beginning of period
End of period
Supplemental disclosure of cash flow information:
Cash paid for amounts included in the measurement of lease liability
Non-cash investing and financing activities:
Deferred offering costs included in accounts payable and accrued liabilities
Deemed dividend on modification of common stock warrants
Deferred offering costs included in other non-current assets
Purchases of property and equipment included in accounts payable and accrued liabilities
Right-of-use assets obtained in exchange for lease liability
Leasehold improvements obtained in exchange for tenant improvement allowance from lessors
Construction-in-progress obtained in exchange for tenant improvement allowance from lessors

Comments